Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
US10195161B2 · kind B2 · utility
0Cited by
45References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 9, 2016 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Jun 9, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating Leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.